FGI
NVO

Foresight Global Investors’s Novo Nordisk NVO Stock Holding History

Foresight Global Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1M Buy
355,574
+25,323
+8% +$1.2M 8.48% 4
2025
Q4 		$16.8M Buy
330,251
+164,957
+100% +$8.44M 7.91% 5
2025
Q3 		$9.17M Sell
165,294
-76,872
-32% -$4.5M 5.45% 10
2025
Q2 		$16.7M Buy
+242,166
New +$16.5M 11.87% 4
2024
Q3 		– Sell
-101,702
Closed -$14.5M – 50
2024
Q2 		$14.5M Sell
101,702
-47,148
-32% -$6.25M 6.98% 7
2024
Q1 		$19.1M Buy
+148,850
New +$17.7M 9.41% 3

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Foresight Global Investors's NVO Position: Q1 2026 in Review

Foresight Global Investors increased its Novo Nordisk (NVO) stake by 7.7% in Q1 2026, buying an estimated $1.2M and bringing the position to 355,574 shares worth $13.1M. The position accounts for 8.48% of the portfolio, ranked #4.

Foresight Global Investors first reported a position in NVO in Q1 2024 and has held it in 6 quarters since. The position peaked at $19.1M in Q1 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Foresight Global Investors held 355,574 shares of Novo Nordisk worth $13.1M as of Q1 2026.
  • Foresight Global Investors bought 25,323 Novo Nordisk shares in Q1 2026, an estimated $1.2M.
  • Novo Nordisk made up 8.48% of Foresight Global Investors's portfolio in Q1 2026, its #4 holding.
  • Foresight Global Investors first reported a position in Novo Nordisk in Q1 2024 and has held it in 6 quarters since.
  • Foresight Global Investors's Novo Nordisk position peaked at $19.1M in Q1 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Foresight Global Investors's 13F filing for Q1 2026, filed 13 May 2026.